Logo image of ALBOA.PA

BOA CONCEPT SACA (ALBOA.PA) Stock Fundamental Analysis

Europe - EPA:ALBOA - FR0011365907 - Common Stock

17 EUR
0 (0%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ALBOA scores 3 out of 10 in our fundamental rating. ALBOA was compared to 0 industry peers in the Unkown industry. ALBOA has a bad profitability rating. Also its financial health evaluation is rather negative. ALBOA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALBOA has reported negative net income.
In the past year ALBOA has reported a negative cash flow from operations.
ALBOA had positive earnings in 4 of the past 5 years.
In multiple years ALBOA reported negative operating cash flow during the last 5 years.
ALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

The 3 year average ROIC (7.06%) for ALBOA is well above the current ROIC(0.12%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.15%
ROE 1.89%
ROIC 0.12%
ROA(3y)6.65%
ROA(5y)6.64%
ROE(3y)10.34%
ROE(5y)11.59%
ROIC(3y)7.06%
ROIC(5y)N/A
ALBOA.PA Yearly ROA, ROE, ROICALBOA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

ALBOA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ALBOA has declined.
In the last couple of years the Gross Margin of ALBOA has grown nicely.
Industry RankSector Rank
OM 0.3%
PM (TTM) 2.45%
GM 71.87%
OM growth 3Y-71.55%
OM growth 5YN/A
PM growth 3Y-42.99%
PM growth 5YN/A
GM growth 3Y10.58%
GM growth 5YN/A
ALBOA.PA Yearly Profit, Operating, Gross MarginsALBOA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALBOA is destroying value.
ALBOA has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ALBOA has a worse debt to assets ratio.
ALBOA.PA Yearly Shares OutstandingALBOA.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALBOA.PA Yearly Total Debt VS Total AssetsALBOA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 2.23 indicates that ALBOA is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.36 indicates that ALBOA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.02
WACC8.01%
ALBOA.PA Yearly LT Debt VS Equity VS FCFALBOA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.73 indicates that ALBOA has no problem at all paying its short term obligations.
A Quick Ratio of 3.19 indicates that ALBOA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.19
ALBOA.PA Yearly Current Assets VS Current LiabilitesALBOA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALBOA have decreased strongly by -592.90% in the last year.
The earnings per share for ALBOA have been decreasing by -49.40% on average. This is quite bad
The Revenue has grown by 75.84% in the past year. This is a very strong growth!
Measured over the past years, ALBOA shows a decrease in Revenue. The Revenue has been decreasing by -4.24% on average per year.
EPS 1Y (TTM)-592.9%
EPS 3Y-49.4%
EPS 5YN/A
EPS Q2Q%-109.13%
Revenue 1Y (TTM)75.84%
Revenue growth 3Y-4.24%
Revenue growth 5YN/A
Sales Q2Q%159.03%

3.2 Future

Based on estimates for the next years, ALBOA will show a very strong growth in Earnings Per Share. The EPS will grow by 231.66% on average per year.
The Revenue is expected to grow by 16.18% on average over the next years. This is quite good.
EPS Next Y834.62%
EPS Next 2Y231.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.94%
Revenue Next 2Y16.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBOA.PA Yearly Revenue VS EstimatesALBOA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALBOA.PA Yearly EPS VS EstimatesALBOA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBOA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 5.77, the valuation of ALBOA can be described as very cheap.
ALBOA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.77
ALBOA.PA Price Earnings VS Forward Price EarningsALBOA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.4
ALBOA.PA Per share dataALBOA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

ALBOA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALBOA's earnings are expected to grow with 231.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y231.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALBOA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOA CONCEPT SACA

EPA:ALBOA (10/21/2025, 7:00:00 PM)

17

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.49M
Analysts86.67
Price Target22.44 (32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.77
P/S 1.27
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.11
EV/EBITDA 41.4
EPS(TTM)-0.51
EYN/A
EPS(NY)2.95
Fwd EY17.33%
FCF(TTM)-9.61
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS13.43
BVpS17.33
TBVpS15.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 1.89%
ROCE 0.17%
ROIC 0.12%
ROICexc 0.18%
ROICexgc 0.21%
OM 0.3%
PM (TTM) 2.45%
GM 71.87%
FCFM N/A
ROA(3y)6.65%
ROA(5y)6.64%
ROE(3y)10.34%
ROE(5y)11.59%
ROIC(3y)7.06%
ROIC(5y)N/A
ROICexc(3y)18.28%
ROICexc(5y)N/A
ROICexgc(3y)20.84%
ROICexgc(5y)N/A
ROCE(3y)9.61%
ROCE(5y)N/A
ROICexcg growth 3Y-83.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y-82.81%
ROICexc growth 5YN/A
OM growth 3Y-71.55%
OM growth 5YN/A
PM growth 3Y-42.99%
PM growth 5YN/A
GM growth 3Y10.58%
GM growth 5YN/A
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 15.33
Cap/Depr 2548.21%
Cap/Sales 69.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.19
Altman-Z 2.23
F-Score2
WACC8.01%
ROIC/WACC0.02
Cap/Depr(3y)1077.99%
Cap/Depr(5y)678.81%
Cap/Sales(3y)29.49%
Cap/Sales(5y)20.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-592.9%
EPS 3Y-49.4%
EPS 5YN/A
EPS Q2Q%-109.13%
EPS Next Y834.62%
EPS Next 2Y231.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)75.84%
Revenue growth 3Y-4.24%
Revenue growth 5YN/A
Sales Q2Q%159.03%
Revenue Next Year17.94%
Revenue Next 2Y16.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-97.64%
EBIT growth 3Y-72.75%
EBIT growth 5YN/A
EBIT Next Year975%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-720.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.59%
OCF growth 3YN/A
OCF growth 5YN/A